Bedside saline-contrast electrical impedance tomography for diagnosing acute pulmonary embolism
Official title: A Multicenter Comparative Study of Saline Contrast Electrical Impedance Tomography Method Versus CTPA in the Diagnosis of Acute Pulmonary Embolism
Run by Peking Union Medical College Hospital · NCT07190079 · Data updated 2026-11-12
This study will test whether a bedside saline-contrast electrical impedance tomography (EIT) scan can diagnose acute pulmonary embolism in adults with suspected PE and respiratory failure.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 343 (estimated) |
| Sponsor | Peking Union Medical College Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | September 24, 2025 |
| Main results expected | May 1, 2027 |
| Study ends | September 15, 2027 |
| Registry record updated | October 2, 2025 |
| Trial ID | NCT07190079 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with suspected or confirmed acute pulmonary embolism presenting with acute respiratory failure, who have venous access and can undergo CTPA within 24 hours, are ideal candidates.
✕Probably not a fit
Patients who are pregnant or lactating, have pacemakers or chest wall wounds at electrode sites, severe hypernatremia, BMI over 50, are on ECMO, or cannot hold their breath for the required time are unlikely to benefit or may be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study compares a bedside saline-contrast electrical impedance tomography (EIT) method with standard computed tomography pulmonary angiography (CTPA) for diagnosing acute pulmonary embolism. Patients with suspected or confirmed acute PE and acute respiratory failure will undergo both saline-contrast EIT and CTPA within 24 hours. The EIT procedure uses a short saline bolus injected through central or peripheral venous access while an electrode belt measures impedance changes to map lung perfusion. Study findings will compare EIT and CTPA results for consistency to determine whether EIT reliably detects perfusion defects consistent with PE.
Why it matters
Potential benefit: If successful, this could enable faster bedside detection of PE in unstable patients, reducing the need to move critically ill patients for CT and lowering radiation exposure.
How similar studies have gone: Some small pilot studies have shown that saline-contrast EIT can map pulmonary perfusion, but it remains incompletely validated against CTPA and is not yet widely adopted.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with clinically suspected or confirmed acute pulmonary embolism (PE) presenting with acute respiratory failure; 2. Availability of CTPA results within 24 hours or scheduled to undergo CTPA within the next 24 hours; 3. Age \>18 years; no gender restrictions; 4. Presence of central venous access (internal jugular or subclavian vein) or peripheral forearm venous access; 5. Willingness to participate with signed informed consent from either the patient or legal guardian. Exclusion Criteria: 1. Pregnancy or lactation; 2. Relative contraindications to EIT examination (e.g., chest wall wounds at electrode belt placement site, presence of pacemakers); 3. Severe hypernatremia (serum sodium \>155 mmol/L); 4. Inability to maintain expiratory breath-hold for ≥8 seconds; 5. BMI \>50 or severe thoracic deformities; 6. Current extracorporeal membrane oxygenation (ECMO) therapy.
Where it's running
-
Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Huaiwu He
- Email: tjmuhhw@163.com
- Phone: 01069152301
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prognostic value of the 2026 AHA/ACC PE classification in ED patients with acute PE
This study tests whether the 2026 AHA/ACC five-category PE classification helps predict 30-day major adverse pulmonary embolism events in adults with acute PE presenting to the ED.
-
Real-world use of the EkoSonic Endovascular System for acute pulmonary embolism in Chinese patients
This study tests whether the EkoSonic Endovascular System is safe and effective for Chinese patients with acute pulmonary embolism in routine clinical care.
-
Healthy living strategies to help recover from pulmonary embolism
This study tests if two healthy living strategies can help people recover better after being hospitalized for a pulmonary embolism.
-
Registry of patients with acute cardiovascular disease in a cardiac intensive care unit
This study is looking at patients with serious heart conditions in the Cardiac Intensive Care Unit to see how they do during and after their hospital stay.
-
Using 129Xe MRI to study lung and blood conditions
This study is testing how a special MRI using 129Xe gas can help us understand lung and blood conditions better by looking at healthy people and those with specific lung diseases.
-
Registry of patients with acute pulmonary embolism
This study is collecting information from patients with acute pulmonary embolism to see how different treatments affect their recovery and to help improve care for future patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.